EOLS icon

Evolus

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 81.8%
Negative

Neutral
Business Wire
2 days ago
Evolus to Report First Quarter Financial Results on May 4, 2026
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its first quarter 2026 financial results on Monday, May 4, 2026, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow management's remarks. To partic.
Evolus to Report First Quarter Financial Results on May 4, 2026
Neutral
Business Wire
16 days ago
Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Needham Virtual Healthcare Conference. The fireside chat will take place on Tuesday, April 14, 2026, at 3:45 PM ET. The fireside chat can be accessed on the Investor Relations page of the Evolus website here. A r.
Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference
Neutral
Business Wire
26 days ago
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS) a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during March 2026 of an aggregate of 85,516 restricted stock units (RSUs) and 8,635 stock options of the company's common stock to 10 newly hired non-executive employees of the company. The awards were approved by the compensation committee of the company's board of directors under the Evolus' 2023 Inducemen.
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Positive
The Motley Fool
1 month ago
Why Evolus Stock Soared Today
Demand for Evolus' beauty products is growing. Management expects to generate sustainable profits in 2026.
Why Evolus Stock Soared Today
Neutral
Seeking Alpha
1 month ago
Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript
Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript
Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates
Evolus, Inc. (EOLS) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.01 per share a year ago.
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates
Neutral
Business Wire
1 month ago
Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the fourth quarter and full-year ended December 31, 2025. “In 2025 we generated nearly $300 million in total net revenue delivering our sixth consecutive year of double-digit growth,” said David Moatazedi, President and Chief Executive Officer of Evolus. “Our performance beauty posit.
Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026
Neutral
Business Wire
1 month ago
Evolus to Participate in The Leerink Partners Global Healthcare Conference
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Leerink Partners Global Healthcare Conference in Miami, FL. The fireside chat will take place on Wednesday, March 11, 2026, at 11:20 AM ET. The fireside chat can be accessed on the Investor Relations page of the.
Evolus to Participate in The Leerink Partners Global Healthcare Conference
Neutral
Zacks Investment Research
1 month ago
Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Evolus (EOLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Neutral
Business Wire
1 month ago
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its fourth quarter and full-year 2025 financial results on Tuesday, March 3, 2026, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow management's.
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026